Carcinoma of the endometrium; 300 patients managed in a District General Hospital

References

• Aalders J., Abeler V., Kolstad P., Onsrud P. Postoperative external irradiation and prognostic parameters in stage 1 endometrial carcinoma. Obstetrics and Gynecology 1980; 56: 419–426
   PubMed Web of Science ®Google Scholar
• Aalders J. G., Abeler V., Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecologic Oncology 1984; 17: 85–103
   PubMed Web of Science ®Google Scholar
• Belinson J. L., Spirou B., McClure M., Badger G., Pretorius R. G., Roland T. A. Stage 1 carcinoma of the endometrium: a five year experience using pre-operative caesium. Gynecologic Oncology 1985; 20: 325–335
   PubMed Web of Science ®Google Scholar
• Boronow R. C.C. P., Creasman W. T., et al. Surgical staging in endometrial cancer: clinical – pathologic findings of a prospective study. Obstetrics and Gynecology 1984; 63: 825–831
   PubMed Web of Science ®Google Scholar
• Burk J. R., Lehman H. F., Wolf F. S. Inadequacy of Papanicolaou smears in the detection of endometrial cancer. New England Journal of Medicine 1974; 291: 191–192
   PubMed Web of Science ®Google Scholar
• Chen S. S., Lee L. Reappraisal of endocervical curettage in predicting cervical involvement by endometrial carcinoma. Journal of Reproductive Medicine 1986; 31: 50–52
   PubMed Web of Science ®Google Scholar
• Christopherson W. M. The significance of the pathological findings in endometrial cancer. Clinics in Obstetrics and Gynaecology 1986; 13: 673–691
   PubMedGoogle Scholar
• Christopherson W. M., Alberhasky R. C., Connelly P. J. Carcinoma of the endometrium. II Papillary adenocarcinoma: a clinical pathological study, 46 cases. American Journal of Clinical Pathology 1982; 77: 534–540
   PubMed Web of Science ®Google Scholar
• Christopherson W. M., Connelly P. J., Alberhasky R. C. Carcinoma of the endometrium. An analysis of prognosticators in patients with favourable subtypes and stage 1 disease. Cancer 1983; 51: 1705–1709
   PubMed Web of Science ®Google Scholar
• Cohen C. J., Buckner H. W., Deppe G., et al. Multidrug treatment of advanced and recurrent endometrial carcinoma: a gynecologic oncology group study. Obstetrics and Gynecology 1984; 63: 719–726
   PubMed Web of Science ®Google Scholar
• Cowles T. A., Magrina J. F., Masterson B. J., Capen C. V. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstetrics and Gynecology 1985; 66: 413–416
   PubMed Web of Science ®Google Scholar
• Creasman W. T. Endometrial Cancer. Clinics in Obstetrics and Gynaecology 1986; 131: 665–842
   Google Scholar
• Deppe G., Jacobs A. J., Bruckner H., Cohen C. J. Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5 fluorouracil and megestrol acetate. American Journal of Obstetrics and Gynecology 1981; 140: 313–315
   PubMed Web of Science ®Google Scholar
• Di Saia P. J., Creasman W. T., Boronow R. C., Blessing J. A. Risk factors and recurrent patterns in stage 1 endometrial cancer. American Journal of Obstetrics and Gynecology 1985; 151: 1009–1015
   PubMed Web of Science ®Google Scholar
• Fortier K. J., Clarke-Pearson D. L., Creasman W. T., Johnson W. W. Fine needle aspiration in gynecology: evaluation of extra pelvic lesions in patients with gynecologic malignancy. Obstetrics and Gynecology 1985; 65: 67–71
   PubMed Web of Science ®Google Scholar
• Feuer G. A., Calanog A. Endometrial carcinoma: treatment of positive para-aortic nodes. Gynecologic Oncology 1987; 27: 104–109
   PubMed Web of Science ®Google Scholar
• Greven K., Olds W. Isolated vaginal recurrences of endometrial adenocarcinoma and their management. Cancer 1987; 60: 419–421
   PubMed Web of Science ®Google Scholar
• Jelen I., Anderson B., Jones N. C., Edinger D. D., Watring W. G. Use of tracheoscopy and directed biopsy for evaluating cervical involvement in endometrial carcinoma. Journal of Reproductive Medicine 1986; 31: 680–683
   PubMed Web of Science ®Google Scholar
• Jones H. W. Editorial comment. Obstetrical and Gynecological Survey 1987; 42: 712–713
   Google Scholar
• Kauppila A., Gronroos M., Nieminen U. Clinical outcome in endometrial cancer. Obstetrics and Gynecology 1982; 61: 473–480
   Google Scholar
• Lewis B. V., Stallworthy J. A., Cowdell R. Adenocarcinoma of the body of the uterus. Journal of Obstetrics and Gynaecology of the British Commonwealth 1970; 77: 343–348
   PubMedGoogle Scholar
• MacDonald P. C., Siiteri P. K. Relationship between extra glandular production of oestrone and endometrial hyperplasia. Gynecologic Oncology 1974; 2: 259
   PubMedGoogle Scholar
• Moazzami B., Van der Walt J. D., Boyd N. R. H. Use of progestagens as an adjuvant to surgery in the treatment of stage 1 adenocarcinoma of the uterine corpus. British Journal of Obstetrics and Gynaecology 1983; 90: 178–181
   PubMedGoogle Scholar
• Oram D., Bridges J. Para-aortic lymphadenec-tomy. Bailliere's Clinical Obstetrics and Gynaecology 1987; 1: 369–380
   PubMedGoogle Scholar
• Pettersson F. Annual Report on the Results of Treatment of Gynaecological Cancer F.l.G.O. 1985; 19: 106–205, 1976–1978
   Google Scholar
• Piver M. S., Lele S. B., Barlow J. J., Blumenson L. Para-aortic lymph node evaluation in stage 1 endometrial carcinoma. Obstetrics and Gynecology 1982; 59: 97–100
   PubMed Web of Science ®Google Scholar
• Quinn M. A., Campbell J. J., Murray R., Pepperell R. J. Tamoxifen and aminoglutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone. Australian and New Zealand Journal of Obstetrics and Gynaecology 1981; 21: 226–229
   PubMed Web of Science ®Google Scholar
• Rutledge F. The role of radical hysterectomy in adenocarcinoma of the endometrium. Gynecologic Oncology 1974; 2: 331–347
   PubMedGoogle Scholar
• Seski J. C., Edwards C. L., Gershenson D. M., Copeland L. J. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer. Obstetrics and Gynecology 1981; 58: 88–91
   PubMed Web of Science ®Google Scholar
• Shimm D. S., Wang C. C., Fuller A. F., et al. Management of high grade stage 1 adenocarcinoma of the endometrium. Hysterectomy following low dose external bean pelvic radiotherapy. Gynecologic Oncology 1986; 69: 872–878
   Google Scholar
• Stock R. J., Gallup D. G. Hysterography in patients with suspected uterine cancer: radiographic and histologic correlations and clinical implications. Obstetrics and Gynecology 1987; 69: 872–878
   PubMed Web of Science ®Google Scholar
• Stokes S., Bedwinek J., Breaux S., Kao M. S., Camel M., Perez C. A. Treatment of stage 1 adenocarcinoma of the endometrium by hysterectomy and irradiation: analysis of complications. Obstetrics and Gynecology 1985; 65: 86–92
   PubMed Web of Science ®Google Scholar
• Valle R. F. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surgery, Gynecology and Obstetrics 1981; 153: 521–526
   PubMedGoogle Scholar
• Vessey M. P., Lawless M. Epidemiology of endometrial cancer. Journal of Obstetrics and Gynaecology 1984; 5: 106–111
   Web of Science ®Google Scholar
• Weiner J., Bigelow B., Demopoulos R. I., Beckman E. M., Weiner I. The value of endocervical sampling in the staging of endometrial carcinoma. Diagnostic Gynecology and Obstetrics 1980; 2: 265–268
   PubMedGoogle Scholar
• Wharton J. T., Mikuta J. J., Mettlin C, et al. Risk factors and current management in carcinoma of the endometrium. Surgery, Gynecology and Obstetrics 1986; 162: 515–520
   PubMedGoogle Scholar
• Yazigi R., Piver M. S., Blumenson L. Malignant peritoneal cytology as prognostic indicator in stage 1 endometrial cancer. Obstetrics and Gynecology 1983; 62: 359–361
   PubMed Web of Science ®Google Scholar